-
Antibody Tests for COVID-19 - Are They the Answer Insurers Have Been Searching For?
By Nabaneeta Sirkar and Dr. Thomas Ashley Apr 28, 2020 English
The novel corona virus-affected world has been inundated with medical testing and related published data like never before. The volume and nature of testing has evolved significantly in the last few weeks. Antibody tests, which reveal whether a person...
Read More -
The Medical Treatment of COVID-19 - Where Do Things Stand Today?
By Dr. Sandra Mitic Apr 23, 2020 English Deutsch
Viruses are tiny organic structures that are able to invade human cells and multiply inside them. The host cells are either destroyed or at least prevented from performing their normal metabolic functions. As the replication mechanism of most viruses...
Read More -
Group Medical EOI - U.S. Benchmarking Survey Identifies Underwriting Challenges
By Joe Iannetti Feb 11, 2020 English
In the fourth quarter of 2019, Gen Re released the results of our Group Medical Evidence of Insurability Underwriting Survey. The survey focused on how companies staff for and process their Evidence of Insurability (EOI) applications; it included Group...
Read More -
Series: SurveysGroup Medical Evidence of Insurability – Highlights of 2019 U.S. Underwriting Survey
Issue: Nov 20, 2019 Life English
Summary of key highlights from our industry survey, with participants tracking EOI data for their Group Term Life, STD and LTD products. Full survey available only to participants.
Read More
